Visionary clarityNext-generation IOL made fromour globally patented cross-linked Polyisobutylene (xPIB)
Eyedeal is committed to helping cataract patients around the world regain their sight
Eyenable foldable intraocular lenses are made of conventional hydrophobic acrylate materials. Eyedeal has mastered the R&D and production of the whole process, from material synthesis and product design to process manufacturing, to provide patients with affordable good performance, high-quality IOLs.
Processed by cross-linked polyisobutylene (xPIB) material.
The Eyedeal series are the world’s latest generation of intraocular lenses. They are made of cross-linked polyisobutylene (xPIB) material. Global experts believe that cross-linked polyisobutylene intraocular lenses have better biocompatibility and stability, as well as excellent optical and mechanical properties. They require only a micro-incision while achieving a large optical surface, and reduce glare (positive and negative dysphotopsia) to provide patients with better intraocular lenses over the long-term.
Eyedeal has a global patent for cross-linked polyisobutylen (xPIB) material technology. This ends China’s reliance on importing high-end medical polymer materials and contributes to the goal of made-in-China products leading the world.
Eyedeal – paying attention to young people’s eye health
Orthokeratology (OK lens) is a rigid contact lens designed with rigid oxygen-permeable materials, which can reverse myopia or slow down the progression of myopia to a certain extent by temporarily changing the corneal shape.
In the “Guidelines for the Prevention and Treatment of Myopia” issued by the National Health and Medical Commission in 2018, orthokeratology lenses are listed as one of the effective methods for the prevention and control of myopia.
Eyedeal develops and designs a new orthokeratology lens
We have synthesized a highly biocompatible material with high oxygen permeability and low wetting angle. Its unique segmented optical design is more in line with the characteristics of the Asian eye and is more comfortable. The new precision machining process produces higher quality products.
Eyedeal ICL – see the wonderful world
Globally, phakic intraocular lenses (Phakic ICL) are widely recognized as an effective option for translating high refractive errors.
Eyedeal uses a new generation of ICLs designed and developed with globally patented cross linked polyisobutylene polymer materials, which have excellent performance and reduce the occurrence of adverse reactions, mainly helping customers with high myopia.
New treatment options for glaucoma patients
Glaucoma is the second leading cause of blindness in the world after cataracts, but the first irreversible cause of blindness.
Treatment of glaucoma
Glaucoma is mainly treated by reducing intraocular pressure to avoid optic nerve damage, or preventing optic nerve damage from continuing to develop.
Minimally invasive glaucoma surgery (MIGS) and glaucoma drainage tube implantation is a relatively simple procedure with few complications with low impact on patient quality of life. It is one of the best treatments for glaucoma.
Eyedeal pioneers and innovates in the field of glaucoma drainage tubes
Eyedeal’s team of ophthalmologists relies on unique material advantages and rich industry experience to develop the first domestic glaucoma drainage tube with independent intellectual property rights. With better biological safety and biological stability, it solves the problems of current drainage tube products
Global patent, broad platform
Eyedeal has cooperated with Dr Leonard Pinchuk, Member of the American Academy of Engineering and recipient of the 2019 Russ Prize, to develop a new medical material – cross-linked polyisobutylene (xPIB).
Crosslinked polyisobutylene (crosslinked polyisobutylene-[CH2-C(CH3)2]n, xPIB) is synthesized from branched olefins and vinyl comonomers through high-temperature chemical cross-linking, which has been proven to have excellent clinical efficacy and biocompatibility.
Advantages of crosslinked polyisobutylene
Homogeneous homopolymer / No hydrolyzable groups / No degradation by-products / Alternating quaternary carbons in the main chain
Eyedeal has independent intellectual property rights and global patents for crosslinked polyisobutylene materials. We focus on other potential application scenarios and explore the infinite possibilities of crosslinked polyisobutylene.
As one of the few medical implantable materials with source innovation and complete intellectual property rights in China, cross-linked polyolefins also have very high value in orthopedics, neurosurgery, thoracic surgery and other fields.
Eyedeal regards R&D and innovation as fundamental. Our scientists and engineers focus on unmet clinical needs, actively expand scientific boundaries, develop new medical materials, and develop more extensive and in-depth product lines.
